Molecular response to imatinib mesylate following relapse after allogeneic SCT for CML
Open Access
- 1 February 2003
- journal article
- Published by American Society of Hematology in Blood
- Vol. 101 (3) , 1200
- https://doi.org/10.1182/blood-2002-09-2932
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Imatinib mesylate therapy for relapse after allogeneic stem cell transplantation for chronic myelogenous leukemiaBlood, 2002
- The impact of clonal evolution on response to imatinib mesylate (STI571) in accelerated phase CMLBlood, 2002
- Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemiaBlood, 2000
- Outcome for patients who relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia. Chronic Leukemia Working Party. European Bone Marrow Transplantation GroupBlood, 1993
- Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantationBlood, 1993
- Evaluation of mixed chimerism by in vitro amplification of dinucleotide repeat sequences using the polymerase chain reactionBlood, 1991